JP2018528176A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018528176A5 JP2018528176A5 JP2018504675A JP2018504675A JP2018528176A5 JP 2018528176 A5 JP2018528176 A5 JP 2018528176A5 JP 2018504675 A JP2018504675 A JP 2018504675A JP 2018504675 A JP2018504675 A JP 2018504675A JP 2018528176 A5 JP2018528176 A5 JP 2018528176A5
- Authority
- JP
- Japan
- Prior art keywords
- acrylate
- drug
- hydrate
- patch
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 claims 17
- 229940079593 drug Drugs 0.000 claims 15
- 150000003839 salts Chemical class 0.000 claims 14
- 238000003860 storage Methods 0.000 claims 6
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims 5
- 239000000178 monomer Substances 0.000 claims 5
- 239000004820 Pressure-sensitive adhesive Substances 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 239000003961 penetration enhancing agent Substances 0.000 claims 4
- 229920000193 polymethacrylate Polymers 0.000 claims 4
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 claims 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims 2
- JOOXCMJARBKPKM-UHFFFAOYSA-N 4-oxopentanoic acid Chemical compound CC(=O)CCC(O)=O JOOXCMJARBKPKM-UHFFFAOYSA-N 0.000 claims 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims 2
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 claims 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 claims 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims 2
- 239000005642 Oleic acid Substances 0.000 claims 2
- 238000002425 crystallisation Methods 0.000 claims 2
- 230000008025 crystallization Effects 0.000 claims 2
- 238000000151 deposition Methods 0.000 claims 2
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 claims 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims 2
- 229940055577 oleyl alcohol Drugs 0.000 claims 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 claims 2
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 claims 1
- WDQMWEYDKDCEHT-UHFFFAOYSA-N 2-ethylhexyl 2-methylprop-2-enoate Chemical compound CCCCC(CC)COC(=O)C(C)=C WDQMWEYDKDCEHT-UHFFFAOYSA-N 0.000 claims 1
- NQSLZEHVGKWKAY-UHFFFAOYSA-N 6-methylheptyl 2-methylprop-2-enoate Chemical compound CC(C)CCCCCOC(=O)C(C)=C NQSLZEHVGKWKAY-UHFFFAOYSA-N 0.000 claims 1
- DXPPIEDUBFUSEZ-UHFFFAOYSA-N 6-methylheptyl prop-2-enoate Chemical compound CC(C)CCCCCOC(=O)C=C DXPPIEDUBFUSEZ-UHFFFAOYSA-N 0.000 claims 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 claims 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 125000005250 alkyl acrylate group Chemical group 0.000 claims 1
- -1 alkyl methacrylate Chemical compound 0.000 claims 1
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- GTBGXKPAKVYEKJ-UHFFFAOYSA-N decyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCOC(=O)C(C)=C GTBGXKPAKVYEKJ-UHFFFAOYSA-N 0.000 claims 1
- FWLDHHJLVGRRHD-UHFFFAOYSA-N decyl prop-2-enoate Chemical compound CCCCCCCCCCOC(=O)C=C FWLDHHJLVGRRHD-UHFFFAOYSA-N 0.000 claims 1
- QQQMUBLXDAFBRH-UHFFFAOYSA-N dodecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)O QQQMUBLXDAFBRH-UHFFFAOYSA-N 0.000 claims 1
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 claims 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 claims 1
- 238000001704 evaporation Methods 0.000 claims 1
- 230000004907 flux Effects 0.000 claims 1
- 239000012458 free base Substances 0.000 claims 1
- 235000013773 glyceryl triacetate Nutrition 0.000 claims 1
- 239000001087 glyceryl triacetate Substances 0.000 claims 1
- LNCPIMCVTKXXOY-UHFFFAOYSA-N hexyl 2-methylprop-2-enoate Chemical compound CCCCCCOC(=O)C(C)=C LNCPIMCVTKXXOY-UHFFFAOYSA-N 0.000 claims 1
- LNMQRPPRQDGUDR-UHFFFAOYSA-N hexyl prop-2-enoate Chemical compound CCCCCCOC(=O)C=C LNMQRPPRQDGUDR-UHFFFAOYSA-N 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- PBOSTUDLECTMNL-UHFFFAOYSA-N lauryl acrylate Chemical compound CCCCCCCCCCCCOC(=O)C=C PBOSTUDLECTMNL-UHFFFAOYSA-N 0.000 claims 1
- 229940040102 levulinic acid Drugs 0.000 claims 1
- 125000005641 methacryl group Chemical group 0.000 claims 1
- 238000000386 microscopy Methods 0.000 claims 1
- NZIDBRBFGPQCRY-UHFFFAOYSA-N octyl 2-methylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C(C)=C NZIDBRBFGPQCRY-UHFFFAOYSA-N 0.000 claims 1
- 229940065472 octyl acrylate Drugs 0.000 claims 1
- ANISOHQJBAQUQP-UHFFFAOYSA-N octyl prop-2-enoate Chemical compound CCCCCCCCOC(=O)C=C ANISOHQJBAQUQP-UHFFFAOYSA-N 0.000 claims 1
- 229960002969 oleic acid Drugs 0.000 claims 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims 1
- ULDDEWDFUNBUCM-UHFFFAOYSA-N pentyl prop-2-enoate Chemical compound CCCCCOC(=O)C=C ULDDEWDFUNBUCM-UHFFFAOYSA-N 0.000 claims 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 claims 1
- NHARPDSAXCBDDR-UHFFFAOYSA-N propyl 2-methylprop-2-enoate Chemical compound CCCOC(=O)C(C)=C NHARPDSAXCBDDR-UHFFFAOYSA-N 0.000 claims 1
- PNXMTCDJUBJHQJ-UHFFFAOYSA-N propyl prop-2-enoate Chemical compound CCCOC(=O)C=C PNXMTCDJUBJHQJ-UHFFFAOYSA-N 0.000 claims 1
- 229960002622 triacetin Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1513442.2A GB201513442D0 (en) | 2015-07-30 | 2015-07-30 | Transdermal patch |
| GB1513442.2 | 2015-07-30 | ||
| PCT/GB2016/052308 WO2017017453A1 (en) | 2015-07-30 | 2016-07-28 | Transdermal delivery system |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018528176A JP2018528176A (ja) | 2018-09-27 |
| JP2018528176A5 true JP2018528176A5 (enExample) | 2019-09-12 |
| JP6793718B2 JP6793718B2 (ja) | 2020-12-02 |
Family
ID=54062903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018504675A Expired - Fee Related JP6793718B2 (ja) | 2015-07-30 | 2016-07-28 | 経皮送達系 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20180221298A1 (enExample) |
| EP (1) | EP3328432A1 (enExample) |
| JP (1) | JP6793718B2 (enExample) |
| KR (1) | KR20180031039A (enExample) |
| CN (1) | CN108136028A (enExample) |
| AR (1) | AR105534A1 (enExample) |
| AU (1) | AU2016298762A1 (enExample) |
| BR (1) | BR112018001564A2 (enExample) |
| CA (1) | CA2994109A1 (enExample) |
| GB (1) | GB201513442D0 (enExample) |
| IL (1) | IL256994A (enExample) |
| MA (1) | MA42522A (enExample) |
| MX (1) | MX2018001320A (enExample) |
| SG (1) | SG10201913253TA (enExample) |
| TW (1) | TW201707693A (enExample) |
| WO (1) | WO2017017453A1 (enExample) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10231248A (ja) * | 1997-02-19 | 1998-09-02 | T T S Gijutsu Kenkyusho:Kk | ジヒドロエトルフィン含有経皮吸収型製剤 |
| US6716449B2 (en) * | 2000-02-08 | 2004-04-06 | Euro-Celtique S.A. | Controlled-release compositions containing opioid agonist and antagonist |
| CN1780611B (zh) * | 2003-04-30 | 2013-01-30 | 珀杜医药公司 | 包括活性剂部分以及在活性剂层远侧的逆转剂的抗改造透皮剂型 |
| RS20050812A (sr) * | 2003-04-30 | 2007-12-31 | Purdue Pharma L.P., | Transdermalni dozni oblik otporan na promene |
| DE102005011517A1 (de) * | 2005-03-10 | 2006-09-21 | Grünenthal GmbH | Transdermales therapeutisches System zur Verabreichung von Analgetika |
| TWI541246B (zh) * | 2008-12-08 | 2016-07-11 | 歐陸斯迪公司 | 二氫羥戊甲嗎啡 |
| GB201309654D0 (en) * | 2013-05-30 | 2013-07-17 | Euro Celtique Sa | Method |
-
2015
- 2015-07-30 GB GBGB1513442.2A patent/GB201513442D0/en not_active Ceased
-
2016
- 2016-07-28 MA MA042522A patent/MA42522A/fr unknown
- 2016-07-28 KR KR1020187005892A patent/KR20180031039A/ko not_active Withdrawn
- 2016-07-28 WO PCT/GB2016/052308 patent/WO2017017453A1/en not_active Ceased
- 2016-07-28 CA CA2994109A patent/CA2994109A1/en not_active Abandoned
- 2016-07-28 BR BR112018001564A patent/BR112018001564A2/pt not_active IP Right Cessation
- 2016-07-28 EP EP16747573.0A patent/EP3328432A1/en not_active Withdrawn
- 2016-07-28 CN CN201680055303.0A patent/CN108136028A/zh active Pending
- 2016-07-28 US US15/748,545 patent/US20180221298A1/en not_active Abandoned
- 2016-07-28 SG SG10201913253TA patent/SG10201913253TA/en unknown
- 2016-07-28 AU AU2016298762A patent/AU2016298762A1/en not_active Abandoned
- 2016-07-28 JP JP2018504675A patent/JP6793718B2/ja not_active Expired - Fee Related
- 2016-07-28 MX MX2018001320A patent/MX2018001320A/es unknown
- 2016-07-29 TW TW105124075A patent/TW201707693A/zh unknown
- 2016-07-29 AR ARP160102319A patent/AR105534A1/es unknown
-
2018
- 2018-01-18 IL IL256994A patent/IL256994A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0784379B2 (ja) | 活性成分としてフィゾステイグミンを有する皮膚経由医薬及びその製造方法 | |
| JP2016520638A5 (enExample) | ||
| WO2004112760A1 (ja) | 医療用経皮吸収テープ製剤用非水性粘着剤並びに医療用経皮吸収テープ製剤およびその製造法 | |
| JP2017519837A (ja) | 経皮送達システム | |
| US20140242151A1 (en) | Adhesive skin patch | |
| EP2938334A1 (en) | Compositions and methods for transdermal delivery of non-steroidal anti-inflammatory agents | |
| CN103338771A (zh) | 贴剂 | |
| ES2745154T3 (es) | Sistema de tratamiento transdérmico que contiene buprenorfina y un alfa-hidroxiácido | |
| TW201605497A (zh) | 貼附劑 | |
| WO2014174564A1 (ja) | メマンチン含有経皮吸収型貼付製剤 | |
| CN108785286A (zh) | 透皮吸收制剂 | |
| JP2015522013A (ja) | ロチゴチン含有経皮吸収製剤 | |
| EA034204B1 (ru) | Дермальная терапевтическая система с высокой адгезивной способностью | |
| WO2019234662A1 (en) | Transdermal drug delivery system containing rotigotine | |
| JP2018528176A5 (enExample) | ||
| TWI772807B (zh) | 外用製劑 | |
| JP6180520B2 (ja) | ロチゴチンを含有した経皮吸収製剤（Ｔｒａｎｓｄｅｒｍａｌｃｏｍｐｏｓｉｔｉｏｎｃｏｍｐｒｉｓｉｎｇｒｏｔｉｇｏｔｉｎｅ） | |
| CN109481423B (zh) | 一种双氯芬酸盐透皮贴剂及其制备方法 | |
| JP2005015353A (ja) | 医療用経皮吸収テープ製剤用水性エマルジョン粘着剤並びに医療用経皮吸収テープ製剤及びその製造法 | |
| WO2012072014A1 (zh) | 一种防止雷沙吉兰挥发的透皮贴片 | |
| TWI576245B (zh) | 具抑制結晶保護膜（離型襯墊）之經皮治療系統 | |
| KR101764929B1 (ko) | 셀레길린-함유 접착 제제 | |
| WO2009113504A1 (ja) | 貼付剤 | |
| JP2021517569A5 (enExample) | ||
| TWI710380B (zh) | 抑制丙烯酸系黏著劑流動之方法及丙烯酸系黏著劑流動抑制劑 |